We currently have a stock shortage of Atenolol-AFT (atenolol 50 mg/10 mL) oral liquid 300 mL in both Australia and New Zealand. The only product currently held by AFT Pharmaceuticals expires in October 2018.
Due to problems at the manufacturing site we do not expect new stock to be available until February 2019. We are working with the manufacturer to expedite production of new stock.
We apologise for any inconvenience that is caused by this out of stock situation but it is due to circumstances outside of our control.
Please confirm your email and profession to access the professional product information & downloads. AFT Pharmaceuticals will not share this information externally.
Licensee Login
Please confirm your email and password to access the licensee product information and downloads. AFT Pharmaceuticals will not share this information externally.
AFT Pharmaceuticals Ltd has become aware of an email spam which may contain malware or be an attempt to obtain personal information of recipients. AFT Pharmaceuticals Ltd does not request payment of invoices through email. It is important that you do not click on any links or images contained within the email.
Should you receive this type of email, please delete it immediately, add the sender to a spam or junk emailing list and run anti-virus software. Should you have any concerns please contact AFT. It appears only Australian email addresses are targeted by this spam, as such as have reported its identification to the Australian Competition and Consumer Commission’s Scamwatch. Should you have any concerns please contact Scamwatch (https://www.scamwatch.gov.au/get-help) or AFT Pharmaceuticals Ltd.
As we become aware of developments we will update this notice accordingly. Thank you for your attention and cooperation on this matter.
